Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma (Q90290846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

title

Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Kalliopi Ioannidou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Olivier Randin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Aikaterini Semilietof

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Hélène Maby-El Hajjami

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Petra Baumgaertner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Dominique Vanhecke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

Daniel E Speiser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

publication date

6 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

published in

Frontiers in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

2115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

copyright license

start time

6 September 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

12 December 2020

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.

1 reference

12 December 2020

Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

1 reference

12 December 2020

A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8( ) T-cell response is much less apparent following secondary challenge

1 reference

12 December 2020

A T cell clone's avidity is a function of its activation state

1 reference

12 December 2020

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity

1 reference

12 December 2020

Manipulation of avidity to improve effectiveness of adoptively transferred CD8( ) T cells for melanoma immunotherapy in human MHC class I-transgenic mice

1 reference

12 December 2020

Adoptive T cell therapy using antigen-specific CD8 T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

12 December 2020

Targeting tumours with genetically enhanced T lymphocytes

1 reference

12 December 2020

Detection of virus-specific T cells and CD8 T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections

1 reference

12 December 2020

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

12 December 2020

Adoptive-cell-transfer therapy for the treatment of patients with cancer

1 reference

12 December 2020

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

12 December 2020

Gene modification strategies to induce tumor immunity.

1 reference

12 December 2020

Functional avidity directs T-cell fate in autoreactive CD4 T cells

1 reference

12 December 2020

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

1 reference

12 December 2020

New generation vaccine induces effective melanoma-specific CD8 T cells in the circulation but not in the tumor site

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Effector and memory CTL differentiation

1 reference

12 December 2020

Mobilizing the low-avidity T cell repertoire to kill tumors

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

Loss of CTL function among high-avidity tumor-specific CD8 T cells following tumor infiltration

1 reference

12 December 2020

Lack of original antigenic sin in recall CD8( ) T cell responses

1 reference

12 December 2020

Understanding the structure and function of the immunological synapse

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

12 December 2020

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.

1 reference

12 December 2020

Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy

1 reference

12 December 2020

Adoptive immunotherapy for cancer: harnessing the T cell response

1 reference

12 December 2020

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

1 reference

12 December 2020

Mechanisms behind Functional Avidity Maturation in T Cells

1 reference

12 December 2020

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

1 reference

12 December 2020

Functional avidity: a measure to predict the efficacy of effector T cells?

1 reference

12 December 2020

MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4 T cells from melanoma patients

1 reference

12 December 2020

Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies

1 reference

12 December 2020

T cell avidity and tumor immunity: problems and solutions

1 reference

12 December 2020

Reproducible selection of high avidity CD8 T-cell clones following secondary acute virus infection

1 reference

12 December 2020

Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.

1 reference

12 December 2020

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells

1 reference

12 December 2020

Signaling and Polarized Communication Across the T Cell Immunological Synapse

1 reference

12 December 2020

Heterogeneity assessment of functional T cell avidity.

1 reference

12 December 2020

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2019.02115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31555299 AND SRC:MED&resulttype=core&format=json

12 April 2020

PubMed publication ID

31555299

1 reference